Medical Gaslighting in Lyme Disease: How Symptom Dismissal Delays Diagnosis
Lyme disease can be difficult to diagnose
Dismissal may contribute to diagnostic delays
Persistent or evolving symptoms deserve reassessment
Medical gaslighting in Lyme disease describes an experience reported by patients whose symptoms are minimized, dismissed, or attributed to psychological causes before an adequate evaluation has been completed.
A patient once told me quietly, “The hardest part wasn’t the Lyme. It was being told it couldn’t be Lyme.”
That statement captures something I have seen repeatedly.
Patients may spend months—or sometimes years—seeking answers. Imaging may be normal. Laboratory testing may be inconclusive. Symptoms such as fatigue, pain, dizziness, cognitive difficulties, or changes in functioning may not fit neatly into a single diagnosis.
When this happens, the problem is not necessarily that a clinician intends to dismiss the patient. A 2026 review proposed a more useful way to understand the problem: medical gaslighting can represent a diagnostic safety vulnerability involving communication failures, cognitive bias, diagnostic overshadowing, premature closure, and failure to reconsider a diagnosis as symptoms evolve.4
This distinction matters. The goal is not to blame clinicians. It is to recognize situations in which important patient information may be discounted and opportunities for reassessment may be missed.
How Symptom Dismissal Happens in Lyme Disease
Medical dismissal is not always intentional.
Diagnosis requires clinicians to make decisions despite uncertainty. Problems can arise when an initial explanation becomes fixed too early—a process sometimes called premature diagnostic closure.
Once symptoms have been attributed to anxiety, stress, a previous diagnosis, or another explanation, new information may be interpreted through that existing framework rather than prompting reconsideration.
The 2026 review describes several processes that can contribute to this problem, including anchoring, confirmation bias, diagnostic overshadowing, communication failures, and insufficient reassessment when symptoms persist or change.4
For patients with Lyme disease, this can be particularly relevant because symptoms may be nonspecific, fluctuate over time, and involve multiple systems. Fatigue, pain, dizziness, cognitive problems, and brain fog can have many possible explanations.
In a survey of nearly 1,000 people who identified as Lyme disease patients, respondents reported seeing a median of 10 clinicians before diagnosis and waiting a median of 7 years from symptom onset to diagnosis.1
What Patients Are Told—And What They Hear
The language varies, but patients may hear statements such as:
- Your tests are normal.
- This sounds like anxiety.
- Your symptoms may be related to stress.
- There is no medical explanation for what you are experiencing.
Sometimes these statements reflect a reasonable differential diagnosis. Anxiety, depression, stress, sleep disorders, and other conditions can produce genuine physical symptoms and deserve appropriate evaluation.
The diagnostic safety problem occurs when one explanation becomes the endpoint rather than part of an ongoing evaluation—particularly when symptoms persist, evolve, or no longer fit the original diagnosis.
Research involving Lyme disease patients has found that some report having their symptoms attributed to psychological or psychosomatic causes before receiving a Lyme disease diagnosis.1
Medical Dismissal as a Diagnostic Safety Problem
The 2026 review offers an important shift in how medical gaslighting can be discussed.4
Rather than treating the term primarily as an accusation of clinician misconduct, the authors describe it as a potential diagnostic safety vulnerability.
That means looking for specific processes that can be improved:
- Was the patient’s history adequately heard and documented?
- Were persistent or changing symptoms reconsidered?
- Did an earlier diagnosis prevent consideration of another explanation?
- Was uncertainty acknowledged?
- Was there a plan for reassessment if the patient’s condition did not improve?
This framework is particularly useful because patients can experience genuine dismissal even when no clinician intended to dismiss them.
Why Reassessment Matters When Symptoms Persist
Diagnosis is not always a single event.
Some illnesses become clearer only over time. Symptoms evolve, new findings emerge, and the clinical picture may eventually differ substantially from what was present during the first visit.
The 2026 review emphasizes the importance of longitudinal reassessment, particularly when initial testing is normal or inconclusive and symptoms continue to evolve.4
For Lyme disease, this does not mean that every persistent unexplained symptom should be attributed to Lyme disease.
It means that persistent or changing symptoms should not automatically be dismissed simply because an earlier evaluation did not identify their cause.
A reasonable diagnostic approach keeps competing explanations open and asks whether new information warrants reconsidering the original assessment.
Diagnostic Overshadowing Can Hide New Information
Another important concept is diagnostic overshadowing.
This occurs when a patient’s existing diagnosis influences how clinicians interpret subsequent symptoms. For example, symptoms may be attributed to anxiety, depression, a chronic pain condition, or another established diagnosis without fully considering whether something new has developed.
The 2026 review identifies diagnostic overshadowing as one pathway through which patient concerns can be discounted.4
This does not mean psychological diagnoses are incorrect or unimportant. Rather, having one diagnosis should not prevent clinicians from evaluating new or changing symptoms on their own merits.
Why Lyme Patients May Be Vulnerable to Dismissal
Lyme disease may involve the nervous system, joints, heart, cognition, and overall physical functioning. Some symptoms are readily measurable, while others depend heavily on the patient’s description of what has changed.
Symptoms such as pain, fatigue, dizziness, impaired concentration, exercise intolerance, and changes in daily functioning may not always produce an obvious abnormality on routine testing.
Patient reports therefore remain an important source of clinical information.
This is particularly relevant for neurologic Lyme disease, where the presentation may vary substantially among patients.
When Symptoms Are Not Believed
Repeated experiences of dismissal may have consequences beyond the diagnostic delay itself.
Patients may begin preparing extensively for appointments because they fear they will not be believed. Others may become reluctant to seek additional care or may lose trust in clinicians and the healthcare system.
Research in Lyme disease and other chronic illnesses has described emotional distress and loss of trust associated with repeated experiences of medical invalidation or dismissal.1,2
These experiences do not establish that every disagreement between a patient and clinician represents medical gaslighting. Clinicians and patients can reasonably disagree about diagnoses and treatment.
The concern is a pattern in which symptoms or functional changes are repeatedly minimized without adequate evaluation or reconsideration.
What Clinicians Can Do Differently
The diagnostic-safety approach also provides practical ways to reduce the risk of dismissal.
The 2026 review recommends strategies that include:
- Structured elicitation and documentation of patient and caregiver concerns.
- A diagnostic pause when symptoms persist, evolve, or conflict with the initial diagnosis.
- Explicit discussion of diagnostic uncertainty and alternative explanations.
- Clear instructions about when symptoms should prompt reassessment.
- Longitudinal tracking of symptoms and functional changes.
- Greater awareness of cognitive biases that can influence diagnostic reasoning.
These strategies do not require clinicians to accept every diagnosis proposed by a patient. They require something more fundamental: remaining willing to reconsider the diagnosis when the clinical course does not unfold as expected.
Why Naming Medical Gaslighting Matters
Naming the experience can help patients describe what happened to them, but the terminology should not become another source of division between patients and clinicians.
The more useful question is not simply, “Was this medical gaslighting?”
It is:
Was important clinical information overlooked, and should the diagnosis have been reconsidered?
That shifts the discussion away from assigning blame and toward improving diagnostic safety.
Frequently Asked Questions
What is medical gaslighting in Lyme disease?
Medical gaslighting is a term used by patients to describe experiences in which symptoms are minimized, dismissed, or attributed to psychological causes without adequate evaluation. A 2026 review suggests that these experiences can also be understood as diagnostic safety vulnerabilities rather than intentional clinician misconduct.
Can medical dismissal delay a Lyme disease diagnosis?
It may. If symptoms are prematurely attributed to another explanation and the diagnosis is not reconsidered when symptoms persist or evolve, opportunities to identify Lyme disease or another illness may be delayed.
Does disagreement with a doctor mean a patient has been medically gaslighted?
No. Diagnostic disagreement is common in medicine. The concern is repeated dismissal or misattribution of clinically important symptoms without adequate evaluation, follow-up, or reassessment.
What is premature diagnostic closure?
Premature diagnostic closure occurs when the diagnostic process stops too early after an initial explanation has been accepted, even though subsequent information may justify reconsidering it.
What is diagnostic overshadowing?
Diagnostic overshadowing occurs when an existing diagnosis—such as a psychiatric, neurologic, or chronic medical condition—causes new symptoms to be attributed automatically to that condition rather than evaluated independently.
What should happen when symptoms persist despite a negative evaluation?
Persistent symptoms do not automatically establish a particular diagnosis, including Lyme disease. However, symptoms that continue, evolve, or conflict with the original explanation may warrant reassessment and reconsideration of the differential diagnosis.
Clinical Takeaway
Medical dismissal should not be viewed simply as a conflict between patients and clinicians.
It can also be viewed as a diagnostic safety problem.
Lyme disease can be difficult to recognize, particularly when symptoms are nonspecific, testing is inconclusive, or the clinical picture evolves over time. Premature closure, diagnostic overshadowing, and failure to reassess persistent symptoms may contribute to missed or delayed diagnoses.
At the same time, keeping Lyme disease in the differential does not mean assuming that every unexplained symptom is caused by Lyme disease.
The goal is to remain curious when the patient’s clinical course does not fit the original explanation.
Related Articles
These related articles explore delayed diagnosis, diagnostic uncertainty, persistent symptoms, and the patient experience with Lyme disease.
Lyme Disease Misdiagnosis: Why It Happens and What to Know
PTSD-Like Symptoms After Medical Dismissal in Lyme Disease
Post-Treatment Lyme Disease Syndrome (PTLDS): Why Symptoms Persist
References
- Fagen JL, Shelton JA, Luché-Thayer J. Medical Gaslighting and Lyme Disease: The Patient Experience. Healthcare (Basel). 2024;12(1):78. doi:10.3390/healthcare12010078.
- Au L, Capotescu C, Eyal G, Finestone G. Long COVID and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM Qual Res Health. 2022;2:100167. doi:10.1016/j.ssmqr.2022.100167.
- Sebring JC. Towards a sociological understanding of medical gaslighting in western health care. Sociol Health Illn. 2021;43(9):1951-1964. doi:10.1111/1467-9566.13367.
- Nagula S, Ahmed N, Shane K, Slonim AD. Reframing Patient and Parental Experience in Pediatric Healthcare: Medical Gaslighting as a Diagnostic Safety Vulnerability. Children (Basel). 2026;13(8):981. doi:10.3390/children13080981.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
I am scheduled for an ablation. My immunity doesn’t seem to exist anymore. Even small cuts become infected even to one I had visitations to an infection specialist. At stay in the hospital for a-fib one doctor said he believed it was lyme carditis.
Is it safe for an ablation? One cardiologists just rolled his eyes at me. The electrophysiologist I saw that recommended an ablation seemed to believe me but I am skeptical about any doctors now. This doctor is from a reputable Boston hospital. Is this safe?
I’m sorry—you’ve been through a lot, and it makes sense to feel unsure.
I can’t weigh in on procedure safety, but it’s reasonable to talk openly with your electrophysiologist about infection concerns and the Lyme question